As more than 400 advocates from across the country convene in Washington, D.C., today and tomorrow for the 8th annual NACDS RxIMPACT Day on Capitol Hill, at least one advocate did some prep work with his representatives’ district offices before coming to D.C.
I believe Congress should look at every opportunity to make sure that pharmacists are allowed to utilize their training to the fullest to provide the services that can improve care, increase access and lower costs.
The Senate this week approved S. 524, the Comprehensive Addiction and Recovery Act (CARA), legislation that would adjust existing authorizations and programs to provide a series of resources and incentives to help healthcare providers, law enforcement officials and state and local governments to expand drug treatment, prevention and recovery efforts.
The Centers for Medicare & Medicaid Services (CMS) announced that it will publish the final average manufacturer price (AMP)-based federal upper limits (FULs) in late March 2016. The final AMP-based FULs will be effective on April 1, 2016, to correspond with the effective date of the final rule.
Vonnie Hampel joined NACDS as the director of federal government affairs last week. Hampel most recently managed health policy issues as a senior legislative assistant and press secretary to Rep. Dave Loebsack (D-IA), a member of the House of Representatives Energy and Commerce Committee.
We appreciate the chance to continue to urge a collaborative approach among enforcement and health authorities alike to address prescription drug abuse while maintaining legitimate access.
The millennial generation’s habits and choices as consumers and voters are subject to great scrutiny in an effort to divine how the generation will influence everything from retail trends to the next president. But, in the last election, millennials had the lowest turnout of any age group.
...getting a flu vaccine this season reduced the risk of having to go to the doctor because of flu by nearly 60 percent.